Terms: = Uterine cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
24 results:
1. A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H; Matsumoto K; Morita M; Nagasawa T; Nishio H; Suzuki J; Nishio S; Kobara H; Yunokawa M; Ariyoshi K; Hirayama T; Tokunaga H; Ukita M; Yoriki K; Mori-Uchino M; Furusawa A; Togami S; Nakamura H; Ishikawa M; Satoh T
Cancer Med; 2024 Mar; 13(5):e6968. PubMed ID: 38491829
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560
[TBL] [Abstract] [Full Text] [Related]
3. Incidence, characteristics, and maternal outcomes of pregnancy with uterine prolapse.
Deshpande RR; Matsuzaki S; Cox KR; Foy OB; Mandelbaum RS; Ouzounian JG; Dancz CE; Matsuo K
Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101020. PubMed ID: 37245607
[TBL] [Abstract] [Full Text] [Related]
4. Disparities in refusal of surgery for gynecologic cancer.
Samuel D; Kwon D; Huang M; Zhao W; Roy M; Tabuyo-Martin A; Siemon J; Schlumbrecht MP; Pearson JM; Sinno AK
Gynecol Oncol; 2023 Jul; 174():1-10. PubMed ID: 37141816
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Mileshkin LR; Moore KN; Barnes EH; Gebski V; Narayan K; King MT; Bradshaw N; Lee YC; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Mathews CA; Buck M; Suder A; Lad TE; Barani IJ; Holschneider CH; Van Dyk S; Quinn M; Rischin D; Monk BJ; Stockler MR
Lancet Oncol; 2023 May; 24(5):468-482. PubMed ID: 37080223
[TBL] [Abstract] [Full Text] [Related]
6. Deep Learning using Pre-Brachytherapy MRI to Automatically Predict Applicator Induced Complex uterine Deformation.
Ghosh S; Punithakumar K; Huang F; Menon G; Boulanger P
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3826-3829. PubMed ID: 36086328
[TBL] [Abstract] [Full Text] [Related]
7. Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
Chinula L; Topazian HM; Mapanje C; Varela A; Chapola J; Limarzi L; Stanley C; Hosseinipour M; Gopal S; Tang JH
Int J Cancer; 2021 Jul; 149(2):371-377. PubMed ID: 33687746
[TBL] [Abstract] [Full Text] [Related]
8. Comparison between bidirectional Stratafix
Nakayama K; Razia S; Ishikawa M; Yamashita H; Ishibashi T; Sasamori H; Sawada K; Kurose S; Sato S; Kyo S
BMC Womens Health; 2020 Aug; 20(1):164. PubMed ID: 32758222
[TBL] [Abstract] [Full Text] [Related]
9. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
[TBL] [Abstract] [Full Text] [Related]
10. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
11. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract] [Full Text] [Related]
13. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract] [Full Text] [Related]
14. Adjuvant Therapy Use and Survival in Stage II Endometrial cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
[TBL] [Abstract] [Full Text] [Related]
16. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
Okuda S; Oshio K; Asada H; Tanimoto A; Jinzaki M; Furuya M; Yoshimura Y; Kuribayashi S
Magn Reson Med Sci; 2012; 11(4):283-9. PubMed ID: 23269015
[TBL] [Abstract] [Full Text] [Related]
17. C-LETZ versus large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia: a randomized controlled trial.
Boonlikit S; Thitisagulwong S
Arch Gynecol Obstet; 2012 Nov; 286(5):1173-9. PubMed ID: 22710953
[TBL] [Abstract] [Full Text] [Related]
18. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.
Obstet Gynecol; 2010 Aug; 116(2 Pt 1):469-472. PubMed ID: 20664421
[TBL] [Abstract] [Full Text] [Related]
19. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
Paton F; Paulden M; Saramago P; Manca A; Misso K; Palmer S; Eastwood A
Health Technol Assess; 2010 May; 14 Suppl 1():55-62. PubMed ID: 20507804
[TBL] [Abstract] [Full Text] [Related]
20. [Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma].
Remonnay R; Morelle M; Pommier P; Haie-Meder C; Quetin P; Kerr C; Delannes M; Castelain B; Peignaux K; Kirova Y; Romestaing P; Williaume D; Krzisch C; Thomas L; Lang P; Baron MH; Cussac A; Lesaunier F; Maillard S; Barillot I; Charra-Brunaud C; Carrère MO; Peiffert D
Cancer Radiother; 2010 Jun; 14(3):161-8. PubMed ID: 20206571
[TBL] [Abstract] [Full Text] [Related]
[Next]
